Sympathovagal imbalance contributes to prehypertension status and cardiovascular risks attributed by insulin resistance, inflammation, dyslipidemia and oxidative stress in first degree relatives of type 2 diabetics.

<h4>Background</h4>Though cardiovascular (CV) risks are reported in first-degree relatives (FDR) of type 2 diabetics, the pathophysiological mechanisms contributing to these risks are not known. We investigated the association of sympathovagal imbalance (SVI) with CV risks in these subje...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gopal Krushna Pal, Chandrasekaran Adithan, Palghat Hariharan Ananthanarayanan, Pravati Pal, Nivedita Nanda, Thiyagarajan Durgadevi, Venugopal Lalitha, Avupati Naga Syamsunder, Tarun Kumar Dutta
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/13c3718cd4c24c57b1ac1af92a975ee1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:13c3718cd4c24c57b1ac1af92a975ee1
record_format dspace
spelling oai:doaj.org-article:13c3718cd4c24c57b1ac1af92a975ee12021-11-18T08:47:08ZSympathovagal imbalance contributes to prehypertension status and cardiovascular risks attributed by insulin resistance, inflammation, dyslipidemia and oxidative stress in first degree relatives of type 2 diabetics.1932-620310.1371/journal.pone.0078072https://doaj.org/article/13c3718cd4c24c57b1ac1af92a975ee12013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24265679/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Though cardiovascular (CV) risks are reported in first-degree relatives (FDR) of type 2 diabetics, the pathophysiological mechanisms contributing to these risks are not known. We investigated the association of sympathovagal imbalance (SVI) with CV risks in these subjects.<h4>Subjects and methods</h4>Body mass index (BMI), basal heart rate (BHR), blood pressure (BP), rate-pressure product (RPP), spectral indices of heart rate variability (HRV), autonomic function tests, insulin resistance (HOMA-IR), lipid profile, inflammatory markers, oxidative stress (OS) marker, rennin, thyroid profile and serum electrolytes were measured and analyzed in subjects of study group (FDR of type 2 diabetics, n = 72) and control group (subjects with no family history of diabetes, n = 104).<h4>Results</h4>BMI, BP, BHR, HOMA-IR, lipid profile, inflammatory and OS markers, renin, LF-HF (ratio of low-frequency to high-frequency power of HRV, a sensitive marker of SVI) were significantly increased (p<0.0001) in study group compared to the control group. SVI in study group was due to concomitant sympathetic activation and vagal inhibition. There was significant correlation and independent contribution of markers of insulin resistance, dyslipidemia, inflammation and OS to LF-HF ratio. Multiple-regression analysis demonstrated an independent contribution of LF-HF ratio to prehypertension status (standardized beta 0.415, p<0.001) and bivariate logistic-regression showed significant prediction (OR 2.40, CI 1.128-5.326, p = 0.002) of LF-HF ratio of HRV to increased RPP, the marker of CV risk, in study group.<h4>Conclusion</h4>SVI in FDR of type 2 diabetics occurs due to sympathetic activation and vagal withdrawal. The SVI contributes to prehypertension status and CV risks caused by insulin resistance, dyslipidemia, inflammation and oxidative stress in FDR of type 2 diabetics.Gopal Krushna PalChandrasekaran AdithanPalghat Hariharan AnanthanarayananPravati PalNivedita NandaThiyagarajan DurgadeviVenugopal LalithaAvupati Naga SyamsunderTarun Kumar DuttaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 11, p e78072 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gopal Krushna Pal
Chandrasekaran Adithan
Palghat Hariharan Ananthanarayanan
Pravati Pal
Nivedita Nanda
Thiyagarajan Durgadevi
Venugopal Lalitha
Avupati Naga Syamsunder
Tarun Kumar Dutta
Sympathovagal imbalance contributes to prehypertension status and cardiovascular risks attributed by insulin resistance, inflammation, dyslipidemia and oxidative stress in first degree relatives of type 2 diabetics.
description <h4>Background</h4>Though cardiovascular (CV) risks are reported in first-degree relatives (FDR) of type 2 diabetics, the pathophysiological mechanisms contributing to these risks are not known. We investigated the association of sympathovagal imbalance (SVI) with CV risks in these subjects.<h4>Subjects and methods</h4>Body mass index (BMI), basal heart rate (BHR), blood pressure (BP), rate-pressure product (RPP), spectral indices of heart rate variability (HRV), autonomic function tests, insulin resistance (HOMA-IR), lipid profile, inflammatory markers, oxidative stress (OS) marker, rennin, thyroid profile and serum electrolytes were measured and analyzed in subjects of study group (FDR of type 2 diabetics, n = 72) and control group (subjects with no family history of diabetes, n = 104).<h4>Results</h4>BMI, BP, BHR, HOMA-IR, lipid profile, inflammatory and OS markers, renin, LF-HF (ratio of low-frequency to high-frequency power of HRV, a sensitive marker of SVI) were significantly increased (p<0.0001) in study group compared to the control group. SVI in study group was due to concomitant sympathetic activation and vagal inhibition. There was significant correlation and independent contribution of markers of insulin resistance, dyslipidemia, inflammation and OS to LF-HF ratio. Multiple-regression analysis demonstrated an independent contribution of LF-HF ratio to prehypertension status (standardized beta 0.415, p<0.001) and bivariate logistic-regression showed significant prediction (OR 2.40, CI 1.128-5.326, p = 0.002) of LF-HF ratio of HRV to increased RPP, the marker of CV risk, in study group.<h4>Conclusion</h4>SVI in FDR of type 2 diabetics occurs due to sympathetic activation and vagal withdrawal. The SVI contributes to prehypertension status and CV risks caused by insulin resistance, dyslipidemia, inflammation and oxidative stress in FDR of type 2 diabetics.
format article
author Gopal Krushna Pal
Chandrasekaran Adithan
Palghat Hariharan Ananthanarayanan
Pravati Pal
Nivedita Nanda
Thiyagarajan Durgadevi
Venugopal Lalitha
Avupati Naga Syamsunder
Tarun Kumar Dutta
author_facet Gopal Krushna Pal
Chandrasekaran Adithan
Palghat Hariharan Ananthanarayanan
Pravati Pal
Nivedita Nanda
Thiyagarajan Durgadevi
Venugopal Lalitha
Avupati Naga Syamsunder
Tarun Kumar Dutta
author_sort Gopal Krushna Pal
title Sympathovagal imbalance contributes to prehypertension status and cardiovascular risks attributed by insulin resistance, inflammation, dyslipidemia and oxidative stress in first degree relatives of type 2 diabetics.
title_short Sympathovagal imbalance contributes to prehypertension status and cardiovascular risks attributed by insulin resistance, inflammation, dyslipidemia and oxidative stress in first degree relatives of type 2 diabetics.
title_full Sympathovagal imbalance contributes to prehypertension status and cardiovascular risks attributed by insulin resistance, inflammation, dyslipidemia and oxidative stress in first degree relatives of type 2 diabetics.
title_fullStr Sympathovagal imbalance contributes to prehypertension status and cardiovascular risks attributed by insulin resistance, inflammation, dyslipidemia and oxidative stress in first degree relatives of type 2 diabetics.
title_full_unstemmed Sympathovagal imbalance contributes to prehypertension status and cardiovascular risks attributed by insulin resistance, inflammation, dyslipidemia and oxidative stress in first degree relatives of type 2 diabetics.
title_sort sympathovagal imbalance contributes to prehypertension status and cardiovascular risks attributed by insulin resistance, inflammation, dyslipidemia and oxidative stress in first degree relatives of type 2 diabetics.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/13c3718cd4c24c57b1ac1af92a975ee1
work_keys_str_mv AT gopalkrushnapal sympathovagalimbalancecontributestoprehypertensionstatusandcardiovascularrisksattributedbyinsulinresistanceinflammationdyslipidemiaandoxidativestressinfirstdegreerelativesoftype2diabetics
AT chandrasekaranadithan sympathovagalimbalancecontributestoprehypertensionstatusandcardiovascularrisksattributedbyinsulinresistanceinflammationdyslipidemiaandoxidativestressinfirstdegreerelativesoftype2diabetics
AT palghathariharanananthanarayanan sympathovagalimbalancecontributestoprehypertensionstatusandcardiovascularrisksattributedbyinsulinresistanceinflammationdyslipidemiaandoxidativestressinfirstdegreerelativesoftype2diabetics
AT pravatipal sympathovagalimbalancecontributestoprehypertensionstatusandcardiovascularrisksattributedbyinsulinresistanceinflammationdyslipidemiaandoxidativestressinfirstdegreerelativesoftype2diabetics
AT niveditananda sympathovagalimbalancecontributestoprehypertensionstatusandcardiovascularrisksattributedbyinsulinresistanceinflammationdyslipidemiaandoxidativestressinfirstdegreerelativesoftype2diabetics
AT thiyagarajandurgadevi sympathovagalimbalancecontributestoprehypertensionstatusandcardiovascularrisksattributedbyinsulinresistanceinflammationdyslipidemiaandoxidativestressinfirstdegreerelativesoftype2diabetics
AT venugopallalitha sympathovagalimbalancecontributestoprehypertensionstatusandcardiovascularrisksattributedbyinsulinresistanceinflammationdyslipidemiaandoxidativestressinfirstdegreerelativesoftype2diabetics
AT avupatinagasyamsunder sympathovagalimbalancecontributestoprehypertensionstatusandcardiovascularrisksattributedbyinsulinresistanceinflammationdyslipidemiaandoxidativestressinfirstdegreerelativesoftype2diabetics
AT tarunkumardutta sympathovagalimbalancecontributestoprehypertensionstatusandcardiovascularrisksattributedbyinsulinresistanceinflammationdyslipidemiaandoxidativestressinfirstdegreerelativesoftype2diabetics
_version_ 1718421306976763904